<DOC>
<DOCNO>EP-0657106</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Hydrogenated fructooligosaccarides
</INVENTION-TITLE>
<CLASSIFICATIONS>A21D218	A23L1236	C07H300	A23G952	C07H306	A23L1052	A23G334	A23L1236	A23G952	A23L1064	C07H1504	A23G334	C07H1500	A23L10528	A23L106	A21D200	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A21D	A23L	C07H	A23G	C07H	A23L	A23G	A23L	A23G	A23L	C07H	A23G	C07H	A23L	A23L	A21D	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A21D2	A23L1	C07H3	A23G9	C07H3	A23L1	A23G3	A23L1	A23G9	A23L1	C07H15	A23G3	C07H15	A23L1	A23L1	A21D2	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The present invention relates to a low-calorie, non-cariogenic sweetener suitable for diabetics comprising (fructosyl)n-mannitol and/or (fructosyl)n-sorbitol, where n = 1-6, or a mixture of these compounds, and a process for the preparation thereof by hydrogenation of homooligomeric fructooligosaccharides.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
SUEDZUCKER AG
</APPLICANT-NAME>
<APPLICANT-NAME>
SUEDZUCKER AKTIENGESELLSCHAFT MANNHEIM/OCHSENFURT
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
KOWALCZYK JOERG DR
</INVENTOR-NAME>
<INVENTOR-NAME>
KUNZ MARKWART DR
</INVENTOR-NAME>
<INVENTOR-NAME>
MUNIR MOHAMMED DR
</INVENTOR-NAME>
<INVENTOR-NAME>
VOGEL MANFRED DR
</INVENTOR-NAME>
<INVENTOR-NAME>
KOWALCZYK, JOERG, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
KUNZ, MARKWART, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
MUNIR, MOHAMMED, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
VOGEL, MANFRED, DR.
</INVENTOR-NAME>
</INVENTORS>
<CLAIMS>
A low-calorie, non-cariogenic sweetener suitable for diabetics,
characterised in that it comprises (fructosyl)
n
-mannitol and/or
(fructosyl)
n
-sorbitol, where n = 1 - 6, or a mixture of these
compounds.
A process for the preparation of the sweetener according to claim
1, characterised in that:


a) first a long-chain inulin with a chain length 
>
 DP20 is
enzymatically hydrolysed to produce homo-oligomeric fructooligosaccharides

of the F-Fn type (fructosyl-fructose type, n =
1 - 6) and hetero-oligomeric fructo-oligosaccharides of the

G-Fn type (glucosyl-fructose type, n = 1 - 6);
b) the homo-oligomeric fructo-oligosaccharides (F-Fn type) are
separated from fructose and the hetero-oligomeric fructooligosaccharides

by chromatographic separation of the
hydrolysate;
c) the homo-oligomeric fructo-oligosaccharides are
hydrogenated, and
d) the resulting mixture is purified and dried by known methods.
A process according to claim 2, characterised in that the inulin is
hydrolysed using an endo-inulinase. 
A process according to either one of claims 2 and 3, characterised
in that the hydrolysate substantially contains reducing fructo-oligosaccharides

after enzymatic splitting.
A process according to any one of claims 2 to 4, characterised in
that the hydrolysate has a dry substance content of reducing

fructo-oligosaccharides of at least 75% after enzymatic splitting.
Use of the sweetener according to claim 1 in foodstuffs and luxury
foods.
A (fructosyl)
n
-mannitol and (fructosyl)
n
-sorbitol mixture, where n =
1 - 6.
2-0-β-D-fructofuranosyl- D-mannitol, 2-0-β-D-fructofuranosyl-D-sorbitol,
2-0-(1-0-β-D-fructofuranosyl)-β-D-fructofuranosyl-D-mannitol,

2-0-(1-0-β-D-fructofuranosyl)-β-D-fructofuranosyl-D-sorbitol,
[2-0-(1-0-β-D-fructofuranosyl)]
2
-β-D-fructofuranosyl-D-mannitol,
[2-0-(1-0-β-D-fructofuranosyl)]
2
-β-D-fructofuranosyl-D-sorbitol.
</CLAIMS>
</TEXT>
</DOC>
